RE-BVS – Piemonte Repository

Sfoglia per AUTORE
OCCELLI M
Collezione AO Cuneo

Items : 10

Patients with cancer and hospital admissions: disease trajectory and strategic choices. in BMJ supportive & palliative care / BMJ Support Palliat Care. 2023 Sep 13:spcare-2023-004574. doi: 10.1136/spcare-2023-004574.

2023
AO Cuneo

Numico G; Ferrua R; Fea E; Giamello J; Colantonio I; Occelli M; Vandone AM; Vanella P; Aimar G; Pisano C; Parlagreco E; Persano I; Milanesio M; Ippoliti R;

The Impact of NUTRItional Status at First Medical Oncology Visit on Clinical Outcomes: The NUTRIONCO Study. in Cancers / Cancers (Basel). 2023 Jun 15;15(12):3206. doi: 10.3390/cancers15123206.

2023
AO Cuneo

Muscaritoli M; Modena A; Valerio M; Marchetti P; Magarotto R; Quadrini S; Narducci F; Tonini G; Grassani T; Cavanna L; Di Nunzio C; Citterio C; Occelli M; Strippoli A; Chiurazzi B; Frassoldati A; Altavilla G; Lucenti A; Nicolis F; Gori S;

Basal and one-month differed neutrophil, lymphocyte and platelet values and their ratios strongly predict the efficacy of checkpoint inhibitors immunotherapy in patients with advanced BRAF wild-type melanoma. in Journal of translational medicine / J Transl Med. 2022 Apr 5;20(1):159. doi: 10.1186/s12967-022-03359-x.

2022
AO Cuneo

Guida M; Bartolomeo N; Quaresmini D; Quaglino P; Madonna G; Pigozzo J; Di Giacomo AM; Minisini AM; Tucci M; Spagnolo F; Occelli M; Ridolfi L; Queirolo P; De Risi I; Valente M; Sciacovelli AM; Chiarion Sileni V; Ascierto PA; Stigliano L; Strippoli S;

No Impact of NRAS Mutation on Features of Primary and Metastatic Melanoma or on Outcomes of Checkpoint Inhibitor Immunotherapy: An Italian Melanoma Intergroup (IMI) Study. in Cancers / Cancers (Basel). 2021 Jan 26;13(3):475. doi: 10.3390/cancers13030475.

2021
AO Cuneo

Ascierto PA; Chiaron Sileni V; Gambale E; Quaresmini D; De Risi I; Queirolo P; Ridolfi L; Occelli M; Spagnolo F; Tucci M; Minisini AM; Di Giacomo AM; Pigozzo J; Quaglino P; Madonna G; Bartolomeo N; Guida M; Stigliano L; Strippoli S; On Behalf Of The Italian Melanoma Intergroup Imi Study;

The prognostic impact of the extent of ulceration in patients with clinical stage I-II melanoma: a multicentre study of the Italian Melanoma Intergroup (IMI). in The British journal of dermatology / Br J Dermatol. 2021 Feb;184(2):281-288. doi: 10.1111/bjd.19120. Epub 2020 Jun 15.

2021
AO Cuneo

Portelli F; Galli F; Cattaneo L; Cossa M; De Giorgi V; Forte G; Fraternali Orcioni G; Gianatti A; Indini A; Labianca A; Maurichi A; Merelli B; Montesco MC; Occelli M; Patuzzo R; Piazzalunga D; Pigozzo J; Quaglino P; Ribero S; Salvatori R; Saraggi D; Sena P; Senetta R; Valeri B; Tanaka M; Fukayama M; Palmieri G; Mandalà M; Massi D; et alii...

Real Life Clinical Management and Survival in Advanced Cutaneous Melanoma: The Italian Clinical National Melanoma Registry Experience. in Frontiers in oncology / Front Oncol. 2021 Jul 8;11:672797. doi: 10.3389/fonc.2021.672797. eCollection 2021.

2021
AOU Alessandria
AO Cuneo

Testori A; Palmieri G; Rossi CR; Gandini S; Budroni M; Celentano E; Toffolutti F; Mastrangelo G; Fabrizio T; Calvani N; Atzori L; Massa D; Gatti A; Grosso F; Cairo G; Occelli M; Guida M; De Giorgi V; Barruscotti S; Marussi D; Giordano M; Ribero S; Quaglino P; Nacchiero E; Giudice G; Tosti G; Pennacchioli E; Caracò C; Vanella V; et alii...

The density and spatial tissue distribution of CD8(+) and CD163(+) immune cells predict response and outcome in melanoma patients receiving MAPK inhibitors. in Journal for immunotherapy of cancer / J Immunother Cancer. 2019 Nov 15;7(1):308. doi: 10.1186/s40425-019-0797-4.

2019
AO Cuneo

Cattaneo L; Carnevale-Schianca F; Baroni G; Queirolo P; Quaglino P; Consoli F; Vallacchi V; Portelli F; Occelli M; Tucci M; Di Giacomo AM; Sileni VC; De Penni R; Guida M; Di Guardo L; Del Vecchio M; Nassini R; De Logu F; Merelli B; Rodolfo M; Valeri B; Cossa M; Rulli E; Massi D; Minisini A; Palmieri G; Rivoltini L; Mandalà M;

Prognostic impact of regression in patients with primary cutaneous melanoma >1 mm in thickness. in Journal of the American Academy of Dermatology / J Am Acad Dermatol. 2019 Jan;80(1):99-105.e5. doi: 10.1016/j.jaad.2018.06.054. Epub 2018 Nov 14.

2019
AO Cuneo

Ribero S; Galli F; Osella-Abate S; Bertero L; Cattaneo L; Merelli B; Tondini C; Ghilardi L; De Giorgi V; Occelli M; Quaglino P; Cassoni P; Palmieri G; Massi D; Mandala M; Ribero S; Galli F; Osella-Abate S; Bertero L; Cattaneo L; Merelli B; Tondini C; Ghilardi L; De Giorgi V; Occelli M; Quaglino P; Cassoni P; Palmieri G; Massi D; et alii...

MicroRNAs role as potential biomarkers and key regulators in melanoma. in Genes, chromosomes & cancer / Genes Chromosomes Cancer. 2017 Jan;56(1):3-10. doi: 10.1002/gcc.22402. Epub 2016 Oct 25.

2017
AO Cuneo

Varamo C; Occelli M; Vivenza D; Merlano M; Lo Nigro C;

Mitotic rate correlates with sentinel lymph node status and outcome in cutaneous melanoma greater than 1 millimeter in thickness: A multi-institutional study of 1524 cases. in Journal of the American Academy of Dermatology / J Am Acad Dermatol. 2017 Feb;76(2):264-273.e2. doi: 10.1016/j.jaad.2016.08.066. Epub 2016 Nov 12.

2017
AO Cuneo

Mandalà M; Galli F; Cattaneo L; Merelli B; Rulli E; Ribero S; Quaglino P; De Giorgi V; Pigozzo J; Sileni VC; Chirco A; Ferrucci PF; Occelli M; Imberti G; Piazzalunga D; Massi D; Tondini C; Queirolo P;